Porton Pharma Solutions Company Description

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial.

It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Porton Pharma Solutions and Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain.

The company operates in China and internationally. The company was formerly known as Porton Fine Chemicals Ltd. and changed its name to Porton Pharma Solutions Ltd. in January 2018.

Porton Pharma Solutions Ltd. was incorporated in 2005 and is headquartered in Chongqing, China.

Porton Pharma Solutions Ltd.

Country	China
Founded	2005
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	4,915
CEO	Nianfeng Ju

Contact Details

Address: No.7, Yuntu Road Chongqing, 400714 China
Phone	86 23 6593 6900
Website	portonpharma.com

Stock Details

Ticker Symbol	300363
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100001S57
SIC Code	2833

Key Executives

Name	Position
Nianfeng Ju	Chairman and GM
Hui Chen	Deputy GM and Chief Financial Officer
Yinchun Bai	Senior Deputy GM and Chief Operating Officer
Wei Pi	Deputy GM and Secretary of the Board of Directors
Po Zhu	Deputy General Manager
Qi Chen	Deputy General Manager